Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Welltower (WELL) Posts Strong Q2 Results with +25% Normalized FFO Growth and Raised 2026 Guidance

Welltower (WELL) Posts Strong Q2 Results with +25% Normalized FFO Growth and Raised 2026 Guidance

Key Takeaways

  • Normalized FFO per share of $1.60 beat the Zacks Consensus Estimate of $1.55 by 3.2%, marking a 25.0% increase year-over-year.
  • Revenue reached $3.54 billion, up 39.1% from the prior year and surpassing analyst expectations of approximately $3.36–$3.43 billion.
  • Total portfolio same-store net operating income (SSNOI) grew 15.5%, fueled by 20.5% SSNOI growth in the Seniors Housing Operating (SHO) portfolio.
  • Full-year 2026 normalized FFO guidance was raised to $6.36–$6.44 per share, up from the prior range of $6.21–$6.35.
  • The quarterly dividend was increased by 15% to $0.85 per share, reflecting confidence in sustained cash flow growth.
  • Shares jumped more than 4% in after-hours trading following the release, extending a year-to-date gain of roughly 36%.

Why This Quarter Matters for Welltower Investors

Welltower Inc. (WELL), one of the largest healthcare real estate investment trusts, reported second-quarter 2026 results on July 27, 2026, after the market close. The company owns a large portfolio of senior housing, post-acute care, and outpatient medical properties across the United States, Canada, and the United Kingdom. This release stood out because the senior housing sector continues to benefit from strong demographic trends—an aging population, higher healthcare spending among older adults, and limited new supply. Welltower’s shift toward the Seniors Housing Operating segment and its acquisition activity made the quarter a meaningful checkpoint on whether the company can maintain its growth trajectory.

The Quarter’s Reported Numbers

Welltower delivered normalized funds from operations of $1.60 per diluted share, above the Zacks Consensus Estimate of $1.55 and up 25.0% from $1.28 in the same quarter last year. This marks the fourth straight quarter of beating consensus FFO estimates. On a GAAP basis, net income attributable to common stockholders was $0.61 per diluted share, compared with $0.45 a year earlier.

Revenue totaled $3.54 billion, a 39.1% increase year-over-year that exceeded the consensus range of roughly $3.36–$3.43 billion. Growth was supported by the Amica Senior Lifestyles acquisition, which closed on April 1, 2026, and added 38 Canadian seniors housing communities for a pro rata purchase price of C$4.1 billion.

The most notable operational figure was total portfolio same-store NOI growth of 15.5%, led by 20.5% growth in the SHO portfolio. Within SHO, same-store revenue rose 9.2%, helped by a 330-basis-point occupancy gain and 5.2% RevPOR growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction to the Results

Shares of WELL closed the regular session at $248.80, down about 1.3%, as some investors waited for the print. After hours the stock rose more than 4% and traded above $258 once the FFO beat, higher guidance, and 15% dividend increase to $0.85 per share were announced. The updated full-year normalized FFO range of $6.36–$6.44 per share (from $6.21–$6.35) showed management’s confidence in the growth outlook. With the stock already up roughly 36% year-to-date and about 57% over the past twelve months, the reaction indicates investors see the results as supporting the premium valuation relative to other REITs.

Key Items to Watch Going Forward

Welltower enters the second half of 2026 with solid momentum. The raised guidance points to continued double-digit FFO growth, and the dividend increase underscores management’s outlook. Several areas will be important to monitor. Integration and performance of the Amica portfolio in Canada will be watched closely, including occupancy and RevPOR trends in those communities. The ongoing shift away from the $7.2 billion Outpatient Medical portfolio through additional dispositions will affect capital allocation and future NOI growth. The balance sheet remains supportive, with Net Debt to Adjusted EBITDA at 2.99x and roughly $9.5 billion in liquidity as of June 30, 2026. The recent issuance of C$1.15 billion in senior unsecured notes at a 3.95% weighted-average coupon provides additional flexibility. Broader industry conditions also remain favorable, with senior housing occupancy reaching about 89.9% in the second quarter and new supply staying near historic lows. Potential headwinds include higher interest costs, labor pressures, and the challenge of sustaining elevated growth rates at larger scale.

Enhancing Portfolio Analysis with AI Tools

When evaluating REITs like WELL or screening for similar healthcare real estate opportunities, I occasionally turn to Tickeron’s AI Screener. It helps filter stocks by industry, technical signals, and other criteria without manually reviewing dozens of charts. The tool has proven useful for quickly identifying names with comparable momentum characteristics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WELL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


WELL in upward trend: price rose above 50-day moving average on August 12, 2026

WELL moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend. In of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in of 350 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 303 cases where WELL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for WELL moved out of overbought territory on July 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for WELL turned negative on July 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WELL broke above its upper Bollinger Band on July 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.639) is normal, around the industry mean (3.264). WELL has a moderately high P/E Ratio (105.130) as compared to the industry average of (49.019). Projected Growth (PEG Ratio) (3.660) is also within normal values, averaging (3.232). WELL has a moderately low Dividend Yield (0.013) as compared to the industry average of (0.056). WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.057).

Industry description

The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.

Market Cap

The average market capitalization across the Publishing: Books/Magazines Industry is 16.55B. The market cap for tickers in the group ranges from 113.09K to 168.93B. WELL holds the highest valuation in this group at 168.93B. The lowest valued company is DIGI at 113.09K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Books/Magazines Industry was -3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 7%. XRN experienced the highest price growth at 3%, while MPT experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Publishing: Books/Magazines Industry was -8%. For the same stocks of the Industry, the average monthly volume growth was 22% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 81
Profit Risk Rating: 64
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
WELL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry PublishingBooksMagazines

Profile
Details
Industry
Real Estate Investment Trusts
Address
4500 Dorr Street
Phone
+1 419 247-2800
Employees
533
Web
http://www.welltower.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.